Phosphodiesterase-4 as a therapeutic target

被引:521
作者
Houslay, MD
Schafer, P
Zhang, KYJ
机构
[1] Univ Glasgow, Div Biochem & Mol Biol, IBLS, Glasgow G12 8QQ, Lanark, Scotland
[2] Celgene, Drug Discovery Dept, Immunotherapeut Div, Summit, NJ 07901 USA
[3] Plexxikon, Dept Biol Struct, Berkeley, CA 94710 USA
基金
英国医学研究理事会;
关键词
D O I
10.1016/S1359-6446(05)03622-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclic AMP (CAMP) is a key second messenger in all cells. It is compartmentalized within cells and its levels are controlled, as a result of spatially discrete signaling cassettes controlling its generation, detection and degradation. Underpinning compartmentalized CAMP signaling are similar to 20 members of the phosphodiesterase-4 (PDE4) family. The selective inhibition of this family generates profound, functional effects and PDE4 inhibitors are currently under development to provide potential, novel therapeutics for the treatment of inflammatory diseases, such as asthma, chronic obstructive pulmonary disease and psoriasis, as well as treating depression and serving as cognitive enhancers. Here, we delineate the range of PDE4 isoforms, their role in signaling, their structural biology and related preclinical and clinical pharmacology.
引用
收藏
页码:1503 / 1519
页数:17
相关论文
共 121 条
[71]   Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B - Consequences for rolipram inhibition [J].
McPhee, I ;
Yarwood, SJ ;
Scotland, G ;
Huston, E ;
Beard, MB ;
Ross, AH ;
Houslay, ES ;
Houslay, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) :11796-11810
[72]   The novel long PDE4A10 cyclic AMP phosphodiesterase shows a pattern of expression within brain that is distinct from the long PDE4A5 and short PDE4A1 isoforms [J].
McPhee, I ;
Cochran, S ;
Houslay, MD .
CELLULAR SIGNALLING, 2001, 13 (12) :911-918
[73]   PDE4D plays a critical role in the control of airway smooth muscle contraction [J].
Méhats, C ;
Jin, SLC ;
Wahlstrom, J ;
Law, E ;
Umetsu, DT ;
Conti, M .
FASEB JOURNAL, 2003, 17 (13) :1831-1841
[74]   Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases [J].
Mongillo, M ;
McSorley, T ;
Evellin, S ;
Sood, A ;
Lissandron, V ;
Terrin, A ;
Huston, E ;
Hannawacker, A ;
Lohse, MJ ;
Pozzan, T ;
Houslay, MD ;
Zaccolo, M .
CIRCULATION RESEARCH, 2004, 95 (01) :67-75
[75]   A macromolecular complex of β2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA [J].
Naren, AP ;
Cobb, B ;
Li, CY ;
Roy, K ;
Nelson, D ;
Heda, GD ;
Liao, J ;
Kirk, KL ;
Sorscher, EJ ;
Hanrahan, J ;
Clancy, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :342-346
[76]   Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: Implications in angiogenesis [J].
Netherton, SJ ;
Maurice, DH .
MOLECULAR PHARMACOLOGY, 2005, 67 (01) :263-272
[77]   The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery [J].
Nikulina, E ;
Tidwell, JL ;
Dai, HN ;
Bregman, BS ;
Filbin, MT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (23) :8786-8790
[78]   Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4) [J].
O'Donnell, JM ;
Zhang, HT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (03) :158-163
[79]   Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells [J].
Ogawa, R ;
Streiff, MB ;
Bugayenko, A ;
Kato, GJ .
BLOOD, 2002, 99 (09) :3390-3397
[80]   Short term feedback regulation of cAMP in FRTL-5 thyroid cells - Role of PDE4D3 phosphodiesterase activation [J].
Oki, N ;
Takahashi, S ;
Hidaka, H ;
Conti, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :10831-10837